Will we see an end to the GLP-1 gold rush?
Healthtech Pigeon
00:00
Why General Catalyst chose non-dilutive funding
Jessica and Belle discuss the revenue‑linked structure, risk allocation, and comparisons to Grammarly's deal.
Play episode from 04:40
Transcript
